Skip to main content
SpringerLink
Log in

Antiplatelet Agents

  • Chapter
  • First Online:
Hemostasis and Thrombosis

Abstract

This chapter discusses agents that inhibit platelet function—aspirin, P2Y12 receptor blockers, Gp IIb/IIIa inhibitors, and other agents. The mechanism of action, indications, and toxicities are discussed for each agent.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Suggested Reading (See Also Chap. 20)

  • Anonymous. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324(7329):71–86.

    Article  Google Scholar 

  • Antithrombotic Trialists’ (ATT) Collaboration, Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373(9678):1849–60.

    Article  PubMed  Google Scholar 

  • Bonhomme F, Fontana P, Reny JL. How to manage prasugrel and ticagrelor in daily practice. Eur J Intern Med. 2014;25(3):213–20.

    Article  CAS  PubMed  Google Scholar 

  • Eikelboom JW, Hirsh J, Spencer FA, Baglin TP, Weitz JI. Antiplatelet drugs: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e89S–119. doi:10.1378/chest.11-2293.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Ferri N, Corsini A, Bellosta S. Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties. Drugs. 2013;73(15):1681–709.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pathology and Pediatrics, Oregon Health and Science University, Portland, OR, 97239, USA

    Thomas G. DeLoughery M.D., F.A.C.P., F.A.W.M. (Professor of Medicine)

Authors
  1. Thomas G. DeLoughery M.D., F.A.C.P., F.A.W.M.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas G. DeLoughery M.D., F.A.C.P., F.A.W.M. .

Editor information

Editors and Affiliations

  1. Medicine, Pathology, and Pediatrics, Oregon Health & Science University, Portland, Oregon, USA

    Thomas G. DeLoughery

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

DeLoughery, T.G. (2015). Antiplatelet Agents. In: DeLoughery, T. (eds) Hemostasis and Thrombosis. Springer, Cham. https://doi.org/10.1007/978-3-319-09312-3_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-09312-3_26

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-09311-6

  • Online ISBN: 978-3-319-09312-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation